Abstract:Objective To investigate the clinical risk factors related to the cirrhosis development in patients with hepatitis B virus infection. Methods A total of 988 participants with hepatitis B virus infection were collected for this study in Zhong Shan Hospital affiliated with Fu Dan University between January 2009 and January 2011. All of them were Chinese Han nationality from Shanghai and its surrounding area. Their information, including hepatitis history, serum test, liver imaging, and liver histology if available, were collected. They were divided into healthy recovered and chronic hepatitis group, the later was subdivided into cirrhotic group and non-cirrhotic group. The general informations and clinical determination datas were compared with statistical analysis by using SPSS 18.0 and STATA 11.0 software. Results (1) The ratio of male/female participants was 736/252, and the average age was 50.8±13.2. The numbers of participants in healthy recovered group, non-cirrhotic chronic hepatitis and cirrhotic group were 274, 285, and 429, respectively, and the average ages were 56.7±13.6, 49.2±11.5, and 47.5±13.5, respectively. Chronic hopatitis B (CHB) familial history was found in 2.2% participants of the healthy recovered group and 47.5% participants of chronic hepatitis group. The vertical infection rates were 56.3% in healthy recovered group, and 93.7% in chronic hepatitis group, which have significant difference between them. For chronic hepatitis group, the vertical rates of non-cirrhotic and cirrhotic group were 89.4% and 96.4%, respectively, which also have significant difference between them. The vertical infection was a risk factor for chronicity of hepatitis B (OR=15.02, 95% CI:9.57-23.94) and the development of cirrhosis (OR=3.15, 95%CI:1.39-7.45). The duration of disease of cirrhotic patients (44.1±9.5 years) was longer than that of non-cirrhotic CHB patients (39.3±9.8 years). The ratio of male patients in cirrhotic group was also significantly higher than that in non-cirrhotic group (70.2%) and the duration of disease for male patients (41.7±9.3 years) were shorter than that of female patients (45.0±11.4 years).(2) The levels of liver function rests were significantly different among healthy recover, non-cirrhotic, and cirrhotic group of CHB patients. There were negative correlation between HBsAg and HBV DNA in HBeAg positive patients (r=-0.43);However positive correlation in HBeAg negative patients (r=0.23) was observed. HBsAg level, which was higher than 1 000 COI, of cirrhotic patients (89.5%) was significant higher than that of non-cirrhotic patients (89.5%) (OR=1.86, 95% CI:1.18-2.94). No correlation was found betweem HBV DNA level and the duration of disease of CHB (P=0.21). Although HBV DNA level in cirrhotic group was significantly higher than that in non-cirrhotic group (2.875±2.68 log10copies/mL), the ratio of patients with HBV DNA level, which was higher than 5 log10copies/mL in cirrhotic group (31%) was significantly lower than that in non-cirrhotic group(57.2%). Conclusion The factors associated with cirrhosis development in CHB patients include duration of diseases, familial history, route of infection (vertical infection), male gender, the level of HBsAg(higher than 1 000 COI), and HBV DNA level.

Correlative Factors of Cholelithiasis with Hepatocirrhosis

Correlative factors of polypoid lesions of gallbladder in 1095 cases

Hepatitis C Virus Infection is Positively Associated with Gallstones in Liver Cirrhosis.

Characteristics of serum lipids,leptin,cholecystokinin and bile lipids in patients with cholecystolithiasis

Factors Influencing the Prevalence of Gallstones in Liver Cirrhosis

Prognostic Factors of Hepatolithiasis With Cholangiocarcinoma

Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China.

Risk Factors of Atrial Arrhythmia in Patients with Liver Cirrhosis: A Retrospective Study

The relationship of Helicobacter pylori and cholecystolithiasis

Therapy of Cholelithiasis in Patients of Cirrhotic Portal Hypertension (CPH)

Surgical Treatment of Cholelithiasis in Patients with Cirrhosis

Biliary manometry in patients with cholelithiasis

Treatment of Hepatolithiasis by Hepatectomy and Choledochofiberscopy

A Clinical Study on Relationship Between Liver Cirrhosis and Helicobacter Pylori

High Association between Gallstones and Incidence of Cirrhosis in Chinese Chronic Hepatitis B Patients

Precirrhotic Primary Biliary Cholangitis with Portal Hypertension: Bile Duct Injury Correlate

Correlation between chronic hepatitis B and serum triglyceride and cholesterol levels

Evaluation of the clinical risk factors associated with liver cirrhosis in patients with chronic hepatitis B viral infection

Is There a Correlation between Helicobacter Pylori and Enterohepatic Helicobacter Species and Gallstone Cholecystitis?

Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study

Complex Cystic Duct is Associated With Cholelithiasis